Cutlass Capital invest in the healthcare industry and is a private venture capital partnership.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 31, 2011
NeuroPace
|
Series Unknown | $49M | Health Care | — |
Apr 7, 2010
Hemosphere
|
Series A | $9.30M | Health Care | — |
Mar 2, 2009
GI Dynamics
|
Series C | $15M | Biotechnology | — |
Aug 5, 2008
Xoft
|
Series E | $25M | Advanced Materials | — |
Jul 15, 2008
CardioKinetix
|
Series C | $14.50M | Biotechnology | Yes |
Cutlass Capital has had 7 exits. Cutlass Capital most notable exits include NeuroPace , TranS1
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Apr 21, 2021 | NeuroPace | IPO | Health Care | Detail |
Dec 1, 2017 | TranS1 | M&A | Biotechnology | Detail |
May 15, 2012 | Hemosphere | M&A | Health Care | Detail |
Sep 16, 2011 | GI Dynamics | IPO | Biotechnology | Detail |
Dec 16, 2010 | Xoft | M&A | Advanced Materials | Detail |